Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neurotoxicity research

• Publication date

  2016-08-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12640-016-9655-zPMID 27484692
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo‐controlled pilot study

  2017cited by this paper
• Treatment of Severe Alcohol Withdrawal

  2016cited by this paper
• Behavioral sensitization to ethanol: Neural basis and factors that influence its acquisition and expression.

  2016cited by this paper
• Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions

  2016cited by this paper
• Reversal of Alcohol-Induced Dysregulation in Dopamine Network Dynamics May Rescue Maladaptive Decision-making

  2016cited by this paper
• ALCOHOL DEPENDENCE--NEUROBIOLOGY AND TREATMENT.

  2016cited by this paper
• A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.

  2016cited by this paper
• Non Pharmacological Cognitive Enhancers - Current Perspectives.

  2015cited by this paper
• Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond.

  2015cited by this paper
• Long-term use of benzodiazepines: Definitions, prevalence and usage patterns – a systematic review of register-based studies

  2015cited by this paper
• Acamprosate Produces Its Anti-Relapse Effects Via Calcium

  2014cited by this paper
• Gabapentin treatment for alcohol dependence: a randomized clinical trial.

  2014cited by this paper
• Topiramate Treatment of Heavy Drinkers: Moderation by a GRIK1 Polymorphism

  2014cited by this paper
• Complicated alcohol withdrawal presenting as self mutilation.

  2014cited by this paper
• The management of substance abuse in the critically ill.

  2014cited by this paper
• Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis

  2014cited by this paper
• Benzodiazepine dependence and its treatment with low dose flumazenil

  2014cited by this paper
• Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC.

  2014cited by this paper
• Baclofen in the management of cannabis dependence syndrome

  2014cited by this paper
• Efficacy of disulfiram for the treatment of alcohol dependence assessed with a multicenter randomized controlled trial.

  2014cited by this paper
• Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence

  2014cited by this paper
• Pharmacotherapies for cannabis dependence.

  2014cited by this paper
• Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.

  2014cited by this paper
• Cost-effectiveness analysis of baclofen and chlordiazepoxide in uncomplicated alcohol-withdrawal syndrome

  2014influential reference
• GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence

  2014cited by this paper
• Treatment of alcohol dependence: recent progress and reduction of consumption.

  2014cited by this paper
• Use of propofol infusion in alcohol withdrawal-induced refractory delirium tremens.

  2014influential reference
• Low-Dose Topiramate in Alcohol Dependence: A Single-Blind, Placebo-Controlled Study

  2014cited by this paper
• Propofol for benzodiazepine-refractory alcohol withdrawal in a non-mechanically ventilated patient.

  2014influential reference
• A meta-analysis of topiramate's effects for individuals with alcohol use disorders.

  2014cited by this paper
• Acamprosate: An Alcoholism Treatment That May Not Be What We Thought

  2014cited by this paper
• Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.

  2013cited by this paper
• Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study

  2013cited by this paper
• A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.

  2013cited by this paper
• Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study.

  2013cited by this paper
• A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.

  2013cited by this paper
• Gabapentin Versus Chlordiazepoxide for Outpatient Alcohol Detoxification Treatment

  2013influential reference
• Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.

  2013cited by this paper
• Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

  2013cited by this paper
• A double blind randomised comparison of chlordiazepoxide and lorazepam in alcohol withdrawal.

  2013cited by this paper
• Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration

  2013influential reference
• Functional Social Support within a Medical Supervised Outpatient Treatment Program

  2013cited by this paper
• Sodium Oxybate: A Review of Its Use in Alcohol Withdrawal Syndrome and in the Maintenance of Abstinence in Alcohol Dependence

  2013cited by this paper
• The Synthetic Cannabinoid Withdrawal Syndrome

  2013cited by this paper
• A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.

  2013cited by this paper
• Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.

  2013influential reference
• Pregabalin for Alcohol Dependence: A Critical Review of the Literature

  2012cited by this paper
• A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults

  2012cited by this paper
• Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans.

  2012cited by this paper
• Gabapentin combined with naltrexone for the treatment of alcohol dependence.

  2011cited by this paper
• Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.

  2011influential reference
• β1-noradrenergic system of the central amygdala is involved in state-dependent memory induced by a cannabinoid agonist, WIN55,212-2, in rat.

  2011cited by this paper
• A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal.

  2011cited by this paper
• Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.

  2011influential reference
• Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.

  2011cited by this paper
• Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate

  2011influential reference
• Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion.

  2011cited by this paper
• Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity.

  2011cited by this paper
• Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study

  2011cited by this paper
• Modulation of alcohol and nicotine responses through the endogenous opioid system.

  2010cited by this paper
• Opioid antagonists for alcohol dependence.

  2010cited by this paper
• Topiramate in the treatment of alcohol dependence: a meta-analysis.

  2010cited by this paper
• Suicidal Behavior and Alcohol Abuse

  2010cited by this paper
• Medications acting on the GABA system in the treatment of alcoholic patients.

  2010cited by this paper
• Use of propofol as adjuvant therapy in refractory delirium tremens

  2010influential reference
• Increased pain sensitivity in alcohol withdrawal syndrome

  2010cited by this paper
• Benzodiazepines for alcohol withdrawal.

  2010cited by this paper
• Baclofen in cannabis dependence syndrome.

  2010cited by this paper
• Opioid antagonism enhances marijuana's effects in heavy marijuana smokers

  2010influential reference
• Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.

  2010cited by this paper
• Topiramato en el tratamiento de la dependencia etílica: un metaanálisis

  2010cited by this paper
• Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment.

  2010cited by this paper
• Disulfiram in severe alcoholism—an open controlled study

  2010cited by this paper
• Opioid antagonists for alcohol dependence.

  2010cited by this paper
• Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence.

  2009cited by this paper
• mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse.

  2009cited by this paper
• Phenobarbital Treatment in a Patient with Resistant Alcohol Withdrawal Syndrome

  2009cited by this paper
• Proof‐of‐concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin

  2009cited by this paper
• Chronic ethanol treatment potentiates ethanol‐induced increases in interstitial nucleus accumbens endocannabinoid levels in rats

  2009cited by this paper
• Open-label trial of acamprosate as a treatment for anxiety.

  2009cited by this paper
• A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.

  2009cited by this paper
• A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.

  2009cited by this paper
• Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence.

  2009cited by this paper
• Early outcomes following low dose naltrexone enhancement of opioid detoxification.

  2009influential reference
• A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.

  2009cited by this paper
• Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.

  2008cited by this paper
• Topiramate for Alcohol Dependence

  2008cited by this paper
• Severity of alcohol withdrawal symptoms depends on developmental stage of Long-Evans rats.

  2008cited by this paper
• Comparing topiramate with naltrexone in the treatment of alcohol dependence.

  2008cited by this paper
• Neuropharmacology of alcohol addiction

  2008cited by this paper
• Nimodipine prior to alcohol withdrawal prevents memory deficits during the abstinence phase.

  2008cited by this paper
• A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.

  2008cited by this paper
• Using topiramate or naltrexone for the treatment of alcohol-dependent patients.

  2008cited by this paper
• Effects of clozapine on ethanol withdrawal syndrome in rats.

  2008cited by this paper
• Alcohol Related Changes in Regulation of NMDA Receptor Functions

  2008cited by this paper
• Marijuana Neurobiology and Treatment

  2008cited by this paper
• Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice.

  2008cited by this paper
• Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

  2008cited by this paper
• alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol.

  2008cited by this paper
• An Epidemiologic Analysis of Co-Occurring Alcohol and Drug Use and Disorders

  2008cited by this paper

• Clinical analysis of alcoholic pellagra: A single‐center retrospective study

  2022cites this paper
• Translation of CUD Therapeutics from Drug Discovery to the Clinic

  2018cites this paper